Ursula von der Leyen says young people give her confidence
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
With Germany facing a surge in Covid cases, the country’s health minister, Karl Lauterbach, has now been forced into a desperate deal to secure additional doses to keep the country’s vaccine programme running in 2022. However, it has been revealed the low number of vaccine supplies was caused by former Health Minister, Jens Spahn, and EU Commission President, Ursula von der Leyen. Neither official pushed for additional vaccine supplies provided under an order option with BioNTech.
According to Bild, the option expired in early autumn and would have given Germany additional doses in January 2022.
Under the agreement signed by the EU, the vaccine can be adopted free of charge if a new variant arises, the German paper reports.
The EU can also give the supplier a three-month notice if it requires more vaccines under the option.
It is estimated by the newspaper, 924 million vaccine doses would have been dispatched to the EU if the option had been taken up.
As the EU and its member states decided Brussels would handle vaccine procurement, the bloc has the ability or final say on deals and whether to take up certain options.
As a result of missing the option, Mr Lauterbach previously admitted Germany may not have enough vaccine doses.
He said: “In the next week we can deliver 1.2 million doses of BioNTech for all of Germany, the following week 800,000 doses and then another 1.2 million doses.
“More is simply not there. We are already using reserves, we are emptying everything.”
JUST IN: Brexit LIVE: Boris in freefall as ALL voters turn on EU deal
On Tuesday, the ministry confirmed it would spend €2.2bn (£1.8billion) on 80 million BioNTech doses via official EU procurement channels.
Germany will also buy up an additional 12 million doses directly.
Earlier this month, the UK Government announced a deal which included 60 million additional doses of the Moderna vaccine and 54 million doses of the Pfizer-BioNTech vaccine.
These 114 million doses will help protect the UK’s vaccine drive in 2022 and 2023.
Rishi Sunak cuts US trip short and rushes back as Omicron explodes [Latest]
Take-at-home Covid drug given to UK patients for first time [Update]
Royal health concern as another princess tests positive for COVID-19 [Insight]
This is in addition to the 35 million additional doses of Pfizer/BioNTech ordered in August for delivery in the second half of next year, and the 60 million Novavax and 7.5 million GSK/Sanofi doses expected in 2022.
Health and Social Care Secretary Sajid Javid said: “Thanks to the Vaccines Taskforce, we have an excellent track record of securing the vaccines the country needs to keep this virus at bay.
“These new deals will future proof the Great British vaccination effort – which has so far delivered more than 115 million first, second and booster jabs across the UK – and will ensure we can protect even more people in the years ahead.
“This is a national mission and our best weapon to deal with this virus and its variants is to get jabs in arms – so when you are called forward, get the jab and get boosted.”
See the latest Covid vaccine stats below and visit InYourArea for all the Covid vaccine latest
Although cases have risen rapidly in the UK, this broad portfolio of vaccine supplies has allowed the Government to upscale the booster programme.
On December 12, 397,532 were vaccinated in the UK but on December 15, 745,183 were given a booster jab – the most since the booster programme began.
A further 600 army personnel have also been dispatched to help with the roll out in England.
Source: Read Full Article